Human Papillomavirus and Related Diseases Report VIET NAM

Similar documents
Human Papillomavirus and Related Diseases Report SOUTH AFRICA

Human Papillomavirus and Related Diseases Report GERMANY

Human Papillomavirus and Related Diseases Report ISRAEL

Cancer incidence and mortality in Europe, 2004

Cancer in Ireland 2013: Annual report of the National Cancer Registry

The Burden of Cancer in Asia

Number. Source: Vital Records, M CDPH

Singapore Cancer Registry Annual Registry Report Trends in Cancer Incidence in Singapore National Registry of Diseases Office (NRDO)

Chapter I Overview Chapter Contents

BRAIN TUMOUR RESEARCH FUNDING FLOWS

The effect of the introduction of ICD-10 on cancer mortality trends in England and Wales

What is HPV? Low-risk HPV types. High-risk HPV types

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

Table 2.2. Cohort studies of consumption of alcoholic beverages and cancer in special populations

Cervical Screening and HPV Vaccine Guidelines In Saudi Arabia. Prof. Mohammed Addar Chairmen Gyneoncology section KKUH, King Saud University

Cancer Screening and Early Detection Guidelines

Section 8» Incidence, Mortality, Survival and Prevalence

Global Cancer Statistics

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers

Hospital-Based Tumor Registry. Srinagarind Hospital, Khon Kaen University

CANCER IN CALIFORNIA

Diagnosis and Treatment of Common Oral Lesions Causing Pain

Canadian Cancer Statistics

HPV Vaccines. What is HPV? Can a vaccine help prevent HPV?

Unsafe abortion incidence and mortality

Cancer in Wales. People living longer increases the number of new cancer cases

Statistics fact sheet

Cancer in Cumbria Jennifer Clay Public Health Intelligence Analyst November

Prostate cancer statistics

Making Sense of Your Pap and HPV Test Results

Canadian Cancer Statistics

The role of cancer registries

Analysis of Population Cancer Risk Factors in National Information System SVOD

NATIONAL GUIDELINE FOR CERVICAL CANCER SCREENING PROGRAMME

chapter 5. Quality control at the population-based cancer registry

Summary of Key Points WHO Position Paper on Vaccines against Human Papillomavirus (HPV) October 2014

Population, Health, and Human Well-Being-- Benin

HPV Clinical Research and Vaccines. Rachel Winer, PhD, MPH Department of Epidemiology University of Washington

Cervical cancer is the second most common cancer among South African women

C a nc e r C e nter. Annual Registry Report

Cancer Incidence and Survival By Major Ethnic Group, England,

Cancer of the Cervix

Cervical cancer screening with the HPV test and the Pap test in women ages 30 and older

in Australia an overview 2012

Media Contacts: Annick Robinson Investor Contacts: Justin Holko (438) (908)

La sopravvivenza dei tumori maligni nei confronti internazionali: anticipazione della diagnosi o modifica del decorso naturale della malattia?

National and International Childhood Cancer Incidence and Time Trends

4/30/2013 HPV VACCINE AND NORTH DAKOTA HPV IMMUNIZATION RATES HUMAN PAPILLOMAVIRUS (HPV) HUMAN PAPILLOMAVIRUS HPV CONTINUED

Cancer Survival - How Long Do People Survive?

Cancer in Florida Hispanics

HUMAN PAPILLOMAVIRUS (HPV) FACT SHEET

Skin Cancer: The Facts. Slide content provided by Loraine Marrett, Senior Epidemiologist, Division of Preventive Oncology, Cancer Care Ontario.

Health Profile for Jersey 2014

Thailand. Country coverage and the methodology of the Statistical Annex of the 2015 HDR

R E X C A N C E R C E N T E R. Annual Report Rex Cancer Care Committee 2012 On behalf of the Rex Cancer Center & Rex Health Care

inflammation of the pancreas and damage to the an increased risk of hypertension, stroke and Table 7.1: Classification of alcohol consumption

The current status of cancer care in Taiwan

GLOBAL CONCERNS ABOUT HPV VACCINES FACT SHEET

)HDWXULQJ &RORUHFWDO &DQFHU

Cancer incidence, mortality and survival by site for 14 regions of the world. Colin D Mathers Cynthia Boschi-Pinto Alan D Lopez Christopher JL Murray

Web portal for information on cancer epidemiology in the Czech Republic

Cancer Facts & Figures for African Americans

Investigating Community Cancer Concerns--Deer Park Community Advisory Council, 2008

Foreword. Kitisak Thepsuwan, M.D. Director of Chonburi Cancer Hospital. Ministry of Public Health. Chonburi, Thailand, 20000

evaluation of cancer hazards Robert A Baan PhD The IARC MONOGRAPHS International Agency for Research on Cancer Lyon, France

Lung Cancer: More than meets the eye

Human Papillomavirus Infection and Oropharyngeal Cancer

Munich Cancer Registry

Burden of Cancer Mississippi. Mississippi State Department of Health

Pap smears, cytology and CCHC lab work and follow up

The Ontario Cancer Registry moves to the 21 st Century

Cancer in Western Australia: Incidence and mortality 2003 and Mesothelioma

Briefing note for countries on the 2015 Human Development Report. Philippines

The third all breast cancer report

CANCER EXPLAINED. Union for International Cancer Control Union Internationale Contre le Cancer

Asbestos-Related Cancer Research and Prevention

19. CANCER OF THE CORPUS UTERI

REFERENCE CODE GDHCER PUBLICAT ION DATE JULY 2015 MULTIPLE MYELOMA EPIDEMIOLOGY FORECAST TO 2023

Chapter 2: Health in Wales and the United Kingdom

Munich Cancer Registry

2004 Update. Sierra Leone

Pediatric Oncology for Otolaryngologists

DELRAY MEDICAL CENTER. Cancer Program Annual Report

Cancer Statistics, 2013

Estimating the Global Burden of Asbestos-related Diseases Using YPLL

AUSTRALIAN VIETNAM VETERANS Mortality and Cancer Incidence Studies. Overarching Executive Summary

Biomedical Engineering for Global Health. Lecture Thirteen

Appendices Bexar County Community Health Assessment Appendices Appendix A 125

Death Data: CDC Wonder, Texas Health Data, and VitalWeb

JESSE HUANG ( 黄 建 始 ),MD,MHPE,MPH,MBA Professor of Epidemiology Assistant President

Non-Hodgkin Lymphoma in Queensland An Overview 2012

Childhood cancer incidence and mortality in Canada

CARDCARE PROTECTOR CERTIFICATE OF INSURANCE

Cancer Survival in New Jersey

New Hampshire Childhood Cancer

PROTOCOL OF THE RITA DATA QUALITY STUDY

NHS cervical screening Helping you decide

Part 4 Burden of disease: DALYs

CONTINUING MEDICAL EDUCATION

Table 1. Underlying causes of death related to alcohol consumption, International Classification of Diseases, Ninth Revision

Transcription:

Human Papillomavirus and Related Diseases Report VIET NAM Version posted at www.hpvcentre.net on 15 December 2016

- ii - Copyright and Permissions ICO Information Centre on HPV and Cancer (HPV Information Centre) 2016 All rights reserved. HPV Information Centre publications can be obtained from the HPV Information Centre Secretariat, Institut Català d Oncologia, Avda. Gran Via de l Hospitalet, 199-203 08908 L Hospitalet del Llobregat (Barcelona) Spain. E-mail: hpvcentre@iconcologia.net. Requests for permission to reproduce or translate HPV Information Centre publications - whether for sale or for noncommercial distribution- should be addressed to the HPV Information Centre Secretariat, at the above address. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part the HPV Information Centre concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers products does not imply that they are endorsed or recommended the HPV Information Centre in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the HPV Information Centre to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the HPV Information Centre be liable for damages arising from its use. The development of this report has been supported by grants from the European Comission (7th Framework Programme grant HEALTH-F3-2010-242061, HEALTH-F2-2011-282562, HPV AHEAD). Recommended citation: Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Viet Nam. Summary Report 15 December 2016. [Date Accessed]

- iii - Executive summary Human papillomavirus (HPV) infection is now a well-established cause of cervical cancer and there is growing evidence of HPV being a relevant factor in other anogenital cancers (anus, vulva, vagina and penis) as well as head and neck cancers. HPV types 16 and 18 are responsible for about 70% of all cervical cancer cases worldwide. HPV vaccines that prevent HPV 16 and 18 infections are now available and have the potential to reduce the incidence of cervical and other anogenital cancers. This report provides key information for Viet Nam on: cervical cancer; other anogenital cancers and head and neck cancers; HPV-related statistics; factors contributing to cervical cancer; cervical cancer screening practices; HPV vaccine introduction; and other relevant immunisation indicators. The report is intended to strengthen the guidance for health policy implementation of primary and secondary cervical cancer prevention strategies in the country. Table 1: Key Statistics Population Women at risk for cervical cancer (Female population aged >=15 years) 36.9 million Burden of cervical cancer and other HPV-related cancers Annual number of cervical cancer cases 5,146 Annual number of cervical cancer deaths 2,423 Crude incidence rates per 100,000 and year: Male Female Cervical cancer - 11.3 Anal cancer 0.1-0.4 0.1-0.4 Vulvar cancer - 0.4-0.9 Vaginal cancer - 0.1-0.2 Penile cancer 0.9-1.7 - Pharynx cancer (excluding nasopharynx) 2.6 0.5 Burden of cervical HPV infection Prevalence (%) of HPV 16 and/or HPV 18 among women with: Normal cytology 2.1 Low-grade cervical lesions (LSIL/CIN-1) 27.4 High-grade cervical lesions (HSIL/CIN-2/CIN-3/CIS) 37.4 Cervical cancer 82.8 Other factors contributing to cervical cancer Smoking prevalence (%), women 1.3 Total fertility rate (live births per women) 2.0 Oral contraceptive use (%) among women 12.3 HIV prevalence (%), adults (15-49 years) 0.5 [0.4-0.5] Sexual behaviour Percentage of 15-year-old who have had sexual intercourse (men/women) 0 / 0 Range of median age at first sexual intercourse (men/women) 23.1-24.2 / 21.0-21.5 Cervical screening practices and recommendations Cervical cancer screening coverage, 6.5% (All women aged 25-64 screened every 3y, WHS 2003 Viet Nam) % (age and screening in- terval, reference) Screening ages (years) - Screening interval (years) or - frequency of screens HPV vaccine HPV vaccine introduction HPV vaccination programme Pilot program Date of HPV vaccination routine immunization programme start - HPV vaccination target age for routine immunization - Full course HPV vaccination coverage for routine immunization: - % (calendar year) Please see the specific sections for more information. The data is the subregion South-Eastern Asia

CONTENTS - iv - Contents Executive summary iii 1 Introduction 2 2 Demographic and socioeconomic factors 4 3 Burden of HPV related cancers 6 3.1 Cervical cancer.............................................. 6 3.1.1 Cervical cancer incidence in Viet Nam............................ 6 3.1.2 Cervical cancer incidence by histology in Viet Nam.................... 10 3.1.3 Cervical cancer incidence in Viet Nam across South-Eastern Asia........... 12 3.1.4 Cervical cancer mortality in Viet Nam............................ 14 3.1.5 Cervical cancer mortality in Viet Nam across South-Eastern Asia........... 18 3.1.6 Cervical cancer incidence and mortality comparison, Premature deaths and disability in Viet Nam....................................... 20 3.2 Anogenital cancers other than the cervix.............................. 22 3.2.1 Anal cancer............................................ 22 3.2.2 Vulvar cancer........................................... 24 3.2.3 Vaginal cancer.......................................... 26 3.2.4 Penile cancer........................................... 28 3.3 Head and neck cancers......................................... 30 3.3.1 Pharyngeal cancer (excluding nasopharynx)........................ 30 4 HPV related statistics 33 4.1 HPV burden in women with normal cervical cytology, cervical precancerous lesions or invasive cervical cancer......................................... 33 4.1.1 HPV prevalence in women with normal cervical cytology................ 34 4.1.2 HPV type distribution among women with normal cervical cytology, precancerous cervical lesions and cervical cancer.............................. 36 4.1.3 HPV type distribution among HIV+ women with normal cervical cytology...... 44 4.1.4 Terminology............................................ 45 4.2 HPV burden in anogenital cancers other than cervix....................... 46 4.2.1 Anal cancer and precancerous anal lesions......................... 46 4.2.2 Vulvar cancer and precancerous vulvar lesions....................... 48 4.2.3 Vaginal cancer and precancerous vaginal lesions..................... 50 4.2.4 Penile cancer and precancerous penile lesions....................... 52 4.3 HPV burden in men........................................... 54 4.4 HPV burden in the head and neck.................................. 55 4.4.1 Burden of oral HPV infection in healthy population.................... 55 4.4.2 HPV burden in head and neck cancers............................ 55 5 Factors contributing to cervical cancer 57 6 Sexual and reproductive health behaviour indicators 59 7 HPV preventive strategies 60 7.1 Cervical cancer screening practices.................................. 60 7.2 HPV vaccination............................................. 62 8 Protective factors for cervical cancer 63

LIST OF CONTENTS - v - 9 Indicators related to immunisation practices other than HPV vaccines 64 9.1 Immunisation schedule......................................... 64 9.2 Immunisation coverage estimates................................... 64 10 Glossary 65

LIST OF FIGURES - vi - List of Figures 1 Viet Nam and South-Eastern Asia............................................... 2 2 Population pyramid of Viet Nam 2015............................................. 4 3 Population trends in four selected age groups in Viet Nam................................. 4 4 Comparison of cervical cancer incidence to other cancers in women of all ages in Viet Nam (estimates for 2012) 7 5 Comparison of age-specific cervical cancer to age-specific incidence of other cancers among women 15-44 years of age in Viet Nam (estimates for 2012)............................................ 8 6 Annual number of cases and age-specific incidence rates of cervical cancer in Viet Nam (estimates for 2012).. 9 7 Time trends in cervical cancer incidence in Viet Nam (cancer registry data)...................... 11 8 Age-standardised incidence rates of cervical cancer of Viet Nam (estimates for 2012)................ 12 9 Comparison of age-specific cervical cancer incidence rates in Viet Nam, within the region, and the rest of world 12 10 Annual number of new cases of cervical cancer by age group in Viet Nam (estimates for 2012)........... 13 11 Comparison of cervical cancer mortality to other cancers in women of all ages in Viet Nam (estimates for 2012) 15 12 Comparison of age-specific mortality rates of cervical cancer to other cancers among women 15-44 years of age in Viet Nam (estimates for 2012)................................................ 16 13 Annual number of deaths and age-specific mortality rates of cervical cancer in Viet Nam (estimates for 2012).. 17 14 Comparison of age-standardised cervical cancer mortality rates in Viet Nam and countries within the region (estimates for 2012)........................................................ 18 15 Comparison of age-specific cervical cancer mortality rates in Viet Nam, within its region and the rest of the world 18 16 Annual deaths number of cervical cancer by age group in Viet Nam (estimates for 2012)............... 19 17 Comparison of age-specific cervical cancer incidence and mortality rates in Viet Nam (estimates for 2012).... 20 18 Comparison of annual premature deaths and disability from cervical cancer in Viet Nam to other cancers among women (estimates for 2008)................................................... 21 19 Anal cancer incidence rates by age group in Viet Nam (cancer registry data)...................... 22 20 Time trends in anal cancer incidence in Viet Nam (cancer registry data)........................ 23 21 Vulvar cancer incidence rates by age group in Viet Nam.................................. 24 22 Time trends in vulvar cancer incidence in Viet Nam (cancer registry data)....................... 25 23 Incidence rates of vaginal cancer by age group in Viet Nam................................ 26 24 Time trends in vaginal cancer incidence in Viet Nam (cancer registry data)...................... 27 25 Incidence rates of penile cancer by age group in Viet Nam................................. 28 26 Time trends in penile cancer incidence in Viet Nam (cancer registry data)....................... 29 27 Comparison of incidence and mortality rates of the pharynx (excluding nasopharynx) by age group and sex in Viet Nam (estimates for 2012). Includes ICD-10 codes: C09-10,C12-14......................... 31 28 Crude age-specific HPV prevalence (%) and 95% confidence interval in women with normal cervical cytology in Viet Nam.............................................................. 34 29 HPV prevalence among women with normal cervical cytology in Viet Nam, by study................. 35 30 HPV 16 prevalence among women with normal cervical cytology in Viet Nam, by study............... 37 31 HPV 16 prevalence among women with low-grade cervical lesions in Viet Nam, by study.............. 37 32 HPV 16 prevalence among women with high-grade cervical lesions in Viet Nam, by study.............. 37 33 HPV 16 prevalence among women with invasive cervical cancer in Viet Nam, by study............... 37 34 Comparison of the ten most frequent HPV oncogenic types in Viet Nam among women with and without cervical lesions................................................................ 38 35 Comparison of the ten most frequent HPV oncogenic types in Viet Nam among women with invasive cervical cancer by histology......................................................... 39 36 Comparison of the ten most frequent HPV types in anal cancer cases in Asia and the rest of the World...... 47 37 Comparison of the ten most frequent HPV types in AIN 2/3 cases in Asia and the rest of the World........ 47 38 Comparison of the ten most frequent HPV types in cases of vulvar cancer in Asia and the rest of the World... 49 39 Comparison of the ten most frequent HPV types in VIN 2/3 cases in Asia and the rest of the World........ 49 40 Comparison of the ten most frequent HPV types in cases of vaginal cancer in Asia and the rest of the World.. 51 41 Comparison of the ten most frequent HPV types in VaIN 2/3 cases in Asia and the rest of the World....... 51 42 Comparison of the ten most frequent HPV types in cases of penile cancer in Asia and the rest of the World... 53 43 Comparison of the ten most frequent HPV types in PeIN 2/3 cases in Asia and the rest of the World........ 53 44 Estimated coverage of cervical cancer screening in Viet Nam, by age and study.................... 61

LIST OF TABLES - 1 - List of Tables 1 Key Statistics............................................................ iii 2 Sociodemographic indicators in Viet Nam........................................... 5 3 Cervical cancer incidence in Viet Nam (estimates for 2012)................................ 6 4 Cervical cancer incidence in Viet Nam by cancer registry.................................. 7 5 Age-standardised incidence rates of cervical cancer in Viet Nam by histological type and cancer registry..... 10 6 Cervical cancer mortality in Viet Nam (estimates for 2012)................................ 14 7 Premature deaths and disability from cervical cancer in Viet Nam, South-Eastern Asia and the rest of the world (estimates for 2008)........................................................ 20 8 Anal cancer incidence in Viet Nam by cancer registry and sex............................... 22 9 Vulvar cancer incidence in Viet Nam by cancer registry................................... 24 10 Vaginal cancer incidence in Viet Nam by cancer registry.................................. 26 11 Penile cancer incidence in Viet Nam by cancer registry................................... 28 12 Incidence and mortality of cancer of the pharynx (excluding nasopharynx) in Viet Nam, South-Eastern Asia and the rest of the world by sex (estimates for 2012). Includes ICD-10 codes: C09-10,C12-14.............. 30 13 Incidence of oropharyngeal cancer in Viet Nam by cancer registry and sex....................... 32 14 Prevalence of HPV16 and HPV18 by cytology in Viet Nam................................. 36 15 Type-specific HPV prevalence in women with normal cervical cytology, precancerous cervical lesions and invasive cervical cancer in Viet Nam................................................... 41 16 Type-specific HPV prevalence among invasive cervical cancer cases in Viet Nam by histology............ 43 17 Studies on HPV prevalence among HIV women with normal cytology in Viet Nam.................. 44 18 Studies on HPV prevalence among anal cancer cases in Viet Nam............................ 46 19 Studies on HPV prevalence among cases of AIN2/3 in Viet Nam............................. 46 20 Studies on HPV prevalence among vulvar cancer cases in Viet Nam........................... 48 21 Studies on HPV prevalence among VIN 2/3 cases in Viet Nam.............................. 48 22 Studies on HPV prevalence among vaginal cancer cases in Viet Nam.......................... 50 23 Studies on HPV prevalence among VaIN 2/3 cases in Viet Nam.............................. 50 24 Studies on HPV prevalence among penile cancer cases in Viet Nam........................... 52 25 Studies on HPV prevalence among PeIN 2/3 cases in Viet Nam.............................. 52 26 Studies on HPV prevalence among men in Viet Nam.................................... 54 27 Studies on HPV prevalence among men from special subgroups in Viet Nam...................... 54 28 Studies on oral HPV prevalence among healthy in Viet Nam............................... 55 29 Studies on HPV prevalence among cases of oral cavity cancer in Viet Nam....................... 55 30 Studies on HPV prevalence among cases of oropharyngeal cancer in Viet Nam..................... 56 31 Studies on HPV prevalence among cases of hypopharyngeal or laryngeal cancer in Viet Nam............ 56 32 Factors contributing to cervical carcinogenesis (cofactors) in Viet Nam......................... 57 33 Percentage of 15-year-olds who have had sexual intercourse in Viet Nam........................ 59 34 Median age at first sex in Viet Nam.............................................. 59 35 Marriage patterns in Viet Nam................................................. 59 36 Main characteristics of cervical cancer screening in Viet Nam............................... 60 37 Estimated coverage of cervical cancer screening in Viet Nam............................... 61 38 HPV vaccine introduction in Viet Nam............................................. 62 39 Prevalence of male circumcision in Viet Nam......................................... 63 40 Prevalence of condom use in Viet Nam............................................. 63 41 General immunization schedule in Viet Nam......................................... 64 42 Immunization coverage estimates in Viet Nam........................................ 64 43 Glossary............................................................... 65

1 INTRODUCTION - 2-1 Introduction Figure 1: Viet Nam and South-Eastern Asia The HPV Information Centre aims to compile and centralise updated data and statistics on human papillomavirus (HPV) and related cancers. This report aims to summarise the data available to fully evaluate the burden of disease in Viet Nam and to facilitate stakeholders and relevant bodies of decision makers to formulate recommendations on cervical cancer prevention. Data include relevant cancer statistic estimates, epidemiological determinants of cervical cancer such as demographics, socioeconomic factors, risk factors, burden of HPV infection, screening and immunisation. The report is structured into the following sections: Section 2, Demographic and socioeconomic factors. This section summarises the socio-demographic profile of country. For analytical purposes, Viet Nam is classified in the geographical region of South-Eastern Asia (Figure 1, lighter blue), which is composed of the following countries: Brunei, Indonesia, Cambodia, Laos, Myanmar, Malaysia, Philippines, Singapore, Thailand, Timor-Leste, Viet Nam. Throughout the report, Viet Nam estimates will be complemented with corresponding regional estimates. Section 3, Burden of HPV related cancers. This section describes the current burden of invasive cervical cancer and other HPV-related cancers in Viet Nam and the South-Eastern Asia region with estimates of prevalence, incidence, and mortality rates. Section 4, HPV related statistics. This section reports on prevalence of HPV and HPV type-specific distribution in Viet Nam, in women with normal cytology, precancerous lesions and invasive cervical cancer. In addition, the burden of HPV in other anogenital cancers (anus, vulva, vagina, and penis) and men are presented.

1 INTRODUCTION - 3 - Section 5, Factors contributing to cervical cancer. This section describes factors that can modify the natural history of HPV and cervical carcinogenesis such as smoking, parity, oral contraceptive use, and co-infection with HIV. Section 6, Sexual and reproductive health behaviour indicators. This section presents sexual and reproductive behaviour indicators that may be used as proxy measures of risk for HPV infection and anogenital cancers. Section 7, HPV preventive strategies. This section presents preventive strategies that include basic characteristics and performance of cervical cancer screening status, status of HPV vaccine licensure introduction, and recommendations in national immunisation programmes. Section 8, Protective factors for cervical cancer. This section presents the prevalence of male circumcision and condom use. Section 9, Indicators related to immunisation practices other than HPV vaccines. This section presents data on immunisation coverage and practices for selected vaccines. This information will be relevant for assessing the country s capacity to introduce and implement the new vaccines. The data are periodically updated and posted on the WHO immunisation surveillance, assessment and monitoring website at http://www.who.int/immunization_monitoring/en/.

2 DEMOGRAPHIC AND SOCIOECONOMIC FACTORS - 4-2 Demographic and socioeconomic factors Figure 2: Population pyramid of Viet Nam 2015 Males Females 80+ 75 79 70 74 65 69 60 64 55 59 50 54 45 49 40 44 35 39 30 34 25 29 20 24 15 19 10 14 5 9 Under 5 567,789 1,308,819 423,374 735,137 543,157 826,539 797,501 1,096,526 1,508,964 1,805,521 2,185,923 2,440,018 2,671,938 2,795,424 2,987,539 3,017,259 3,305,730 3,334,276 3,555,354 3,590,979 3,970,529 3,962,145 4,374,225 4,290,003 4,490,052 4,313,263 3,582,536 3,390,322 3,406,698 3,207,976 3,774,596 3,446,644 4,078,564 3,662,281 Data accessed on 26 Aug 2015. Estimated population in a country, area or region as of 1 July of the year indicated. United Nations, Department of Economic and Social Affairs, Population Division (2015). World Population Prospects: The 2015 Revision. Available at: http://esa.un.org/unpd/wpp/ [Accessed: August 2015] Number of women (in millions) 8 6 4 2 0 Figure 3: Population trends in four selected age groups in Viet Nam Projections Women 15 24 yrs Girls 10 14 yrs 1950 1960 1970 1980 1990 2000 2010 2020 2030 2040 2050 2060 2070 2080 2090 2100 Number of women (in millions) Projections 85 65 All Women 45 Women 25 64 yrs 25 5 1950 1960 1970 1980 1990 2000 2010 2020 2030 2040 2050 2060 2070 2080 2090 2100 Female population trends in Viet Nam Number of women by year and age group Data accessed on 26 Aug 2015. Estimated population in a country, area or region as of 1 July of the year indicated. United Nations, Department of Economic and Social Affairs, Population Division (2015). World Population Prospects: The 2015 Revision. Available at: http://esa.un.org/unpd/wpp/ [Accessed: August 2015]

2 DEMOGRAPHIC AND SOCIOECONOMIC FACTORS - 5 - Table 2: Sociodemographic indicators in Viet Nam Indicator Male Female Total Population in thousands 1,a 46,224.5 47,223.1 93,447.6 Population growth rate (%) α,± - - 0.9 Median age of the population (in years) α, - - 28.5 Population living in urban areas (%) 2,α, - - 30.4 Crude birth rate (births per 1,000) α,± - - 17.0 Crude death rate (deaths per 1,000) α,± - - 5.5 Life expectancy at birth (in years) 3, 70.9 80.4 75.7 Adult mortality rate (probability of dying between 15 and 60 years old per 129.6 68.6 75.7 1,000) 3, Under age five mortality rate (per 1,000 live births) 3, - 23.8 75.7 Density of physicians (per 10,000 population) 4,b,c, - - 11.9 Gross national income per capita (PPP int $) 5, - - 5350 Adult literacy rate (%) (aged 15 and older) 6, 96.3 92.8 94.5 Youth literacy rate (%) (aged 15-24 years) 6, 98.2 98.0 98.1 Net primary school enrollment ratio 6 - - 98.0 Net secondary school enrollment ratio 6 - - - Data accessed on 26 Aug 2015. a Estimated population in a country, area or region as of 1 July of the year indicated. b Density (per 10,000 population) and number of physicians. c Includes generalist medical practitioners and specialist medical practitioners. Year of estimate: ± 2005-2010; 2010; 2013; 2014; 2015; α For methods of estimation, please refer to original source. 1 United Nations, Department of Economic and Social Affairs, Population Division (2015). World Population Prospects: The 2015 Revision. Available at: http://esa.un.org/unpd/wpp/ [Accessed: August 2015] 2 United Nations, Department of Economic and Social Affairs, Population Division (2012). World Urbanization Prospects : The 2011 Revision. CD-ROM Edition - Data in digital form (POP/ DB/WUP/Rev.2011). 3 World Health Statistics 2015. Geneva, World Health Organization, 2013. Available at: http://www.who.int/gho/publications/world_health_statistics/2015/en/ [Accessed on July 2015]. 4 WHO Global Health Workforce Statistics [online database]. Geneva, World Health Organization, 2014. Available at: http://www.who.int/hrh/statistics/hwfstats/[accessed on July 2015] 5 World Development Indicators Database, 2015. Washington, DC, World Bank. Available at: http://databank.worldbank.org/data/reports.aspx?source= world-development-indicators [Accessed on July 2015] 6 UNESCO Institute for Statistics Data Centre [online database]. Montreal, UNESCO Institute for Statistics, 2015. Available at: http://stats.uis.unesco.org [Accessed on July 2015]

3 BURDEN OF HPV RELATED CANCERS - 6-3 Burden of HPV related cancers 3.1 Cervical cancer Cancer of the cervix uteri is the 4th most common cancer among women worldwide, with an estimated 527,624 new cases and 265,672 deaths in 2012 (GLOBOCAN). The majority of cases are squamous cell carcinoma followed by adenocarcinomas. (Vaccine 2006, Vol. 24, Suppl 3; Vaccine 2008, Vol. 26, Suppl 10; Vaccine 2012, Vol. 30, Suppl 5; IARC Monographs 2007, Vol. 90) This section describes the current burden of invasive cervical cancer in Viet Nam and in comparison to geographic region, including estimates of the annual number of new cases, deaths, incidence, and mortality rates. 3.1.1 Cervical cancer incidence in Viet Nam KEY STATS. About 5,146 new cervical cancer cases are diagnosed annually in Viet Nam (estimations for 2012). Cervical cancer ranks* as the 4 th leading cause of female cancer in Viet Nam. Cervical cancer is the 2 th most common female cancer in women aged 15 to 44 years in Viet Nam. * Ranking of cervical cancer incidence to other cancers among all women according to highest incidence rates (ranking 1st). Ranking is based on crude incidence rates (actual number of cervical cancer cases). Ranking using age-standardized rate (ASR) may differ. Table 3: Cervical cancer incidence in Viet Nam (estimates for 2012) Indicator Viet Nam South-Eastern Asia World Annual number of new cancer cases 5,146 50,566 527,624 Crude incidence rate a 11.3 16.6 15.1 Age-standardized incidence rate a 10.6 16.3 14.0 Cumulative risk (%) at 75 years old b 1.1 1.7 1.4 Data accessed on 15 Nov 2015. Incidence data is available from regional data (rates) sources. Incidence rates were estimated from national mortality estimates using modelled survival. For more detailed methods of estimation please refer to http://globocan.iarc.fr/old/method/method.asp?country=704 a Rates per 100,000 women per year. b Cumulative risk (incidence) is the probability or risk of individuals getting from the disease during ages 0-74 years. For cancer, it is expressed as the % of new born children who would be expected to develop from a particular cancer before the age of 75 if they had the rates of cancer observed in the period in the absence of competing causes. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr.

3 BURDEN OF HPV RELATED CANCERS - 7 - Table 4: Cervical cancer incidence in Viet Nam by cancer registry Cancer registry 1 Period N cases a Crude rate b ASR b Hanoi 1993-1997 344 6.1 6.7 Ho Chi Minh City 1995-1998 2,289 23.1 28.8 Data accessed on 05 May 2015. ASR: Age-standardized rate, Standardized rates have been estimated using the direct method and the World population as the reference; Please refer to original source (available at http://ci5.iarc.fr/ci5i-ix/ci5i-ix.htm) a Accumulated number of cases during the period in the population covered by the corresponding registry. b Rates per 100,000 women per year. 1 Parkin, D.M., Whelan, S.L., Ferlay, J., Teppo, L., and Thomas, D.B., eds (2002). Cancer Incidence in Five Continents, Vol. VIII. IARC Scientific Publications No. 155, Lyon, IARC. Figure 4: Comparison of cervical cancer incidence to other cancers in women of all ages in Viet Nam (estimates for 2012) Breast Lung Liver Cervix uteri Stomach Colorectum (a) Corpus uteri Thyroid Leukaemia Nasopharynx Ovary Brain, nervous system Non Hodgkin lymphoma (b) Lip, oral cavity Kidney Pancreas Oesophagus Multiple myeloma Larynx Bladder Other pharynx Gallbladder Hodgkin lymphoma Melanoma of skin Kaposi sarcoma (c) 2.5 2.83.6 0.8 1.72.4 0.8 0.7 0.5 0.5 0.5 0.5 0.4 0.3 0.2 0.1 11.4 12.8 24.4 11.3 10.6 9.3 3.9 4.35.8 0 10 20 30 40 Annual crude incidence rate per 100,000 Viet Nam: Female (All ages) Data accessed on 15 Nov 2015. a Includes anal cancer (C21). b Includes HIV disease resulting in malignant neoplasms (B21). c Includes B21.0 (HIV disease resulting in Kaposi sarcoma). Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr.

3 BURDEN OF HPV RELATED CANCERS - 8 - Figure 5: Comparison of age-specific cervical cancer to age-specific incidence of other cancers among women 15-44 years of age in Viet Nam (estimates for 2012) Breast Cervix uteri Thyroid Stomach Liver Leukaemia Corpus uteri Lung Colorectum (a) Ovary Nasopharynx Brain, nervous system Non Hodgkin lymphoma (b) Lip, oral cavity Kidney Hodgkin lymphoma Pancreas Bladder Oesophagus Multiple myeloma Other pharynx Larynx Kaposi sarcoma (c) Gallbladder Melanoma of skin 3.2 2.8 3.1 3.2 2.1 2.6 2.7 2.1 1.42.1 0.6 0.4 0.3 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 5.1 8.1 14.5 0 5 10 15 20 Annual crude incidence rate per 100,000 Viet Nam: Female (15 44 years) Data accessed on 15 Nov 2015. a Includes anal cancer (C21). b Includes HIV disease resulting in malignant neoplasms (B21). c Includes B21.0 (HIV disease resulting in Kaposi sarcoma). Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr.

3 BURDEN OF HPV RELATED CANCERS - 9 - Figure 6: Annual number of cases and age-specific incidence rates of cervical cancer in Viet Nam (estimates for 2012) 30 20 10 0 15 19 20 24 25 29 30 34 Age specific rates of cervical cancer Annual number of new cases of cervical cancer 35 39 40 44 45 49 50 54 55 59 60 64 65 69 70 74 75+ 3500 3000 2500 2000 1500 1000 500 0 1207* 3337 60 64 yrs: 422 cases 55 59 yrs: 671 cases 50 54 yrs: 799 cases 45 49 yrs: 788 cases 40 44 yrs: 657 cases 601 15 39 40 64 65+ Age group (years) *15-19 yrs: 29 cases. 20-24 yrs: 106 cases. 25-29 yrs: 228 cases. 30-34 yrs: 349 cases. 35-39 yrs: 495 cases. Data accessed on 15 Nov 2015. Rates per 100,000 women per year. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr.

3 BURDEN OF HPV RELATED CANCERS - 10-3.1.2 Cervical cancer incidence by histology in Viet Nam Table 5: Age-standardised incidence rates of cervical cancer in Viet Nam by histological type and cancer registry Carcinoma Cancer registry Period Squamous Adeno Other Unspec. No data avalaible - - - - - Data accessed on 24 Jul 2015. Adeno: adenocarcinoma; Other: Other carcinoma; Squamous: Squamous cell carcinoma; Unspec: Unspecified carcinoma; Standardised rates have been estimated using the direct method and the World population as the references. Rates per 100,000 women per year. Standarized rates have been estimated using the direct method and the World population as the references. Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R and Ferlay J eds (2013). Cancer Incidence in Five Continents, Vol. X (electronic version) Lyon, IARC. http://ci5.iarc.fr

3 BURDEN OF HPV RELATED CANCERS - 11 - Figure 7: Time trends in cervical cancer incidence in Viet Nam (cancer registry data) Cervix uteri Annual crude incidence rate (per 100,000) No data available All ages (2) 15 44 yrs (2) 45 74 yrs (2) 1975 1980 1985 1990 1995 Cervix uteri: Squamous cell carcinoma Annual crude incidence rate (per 100,000) No data available All ages (2) 15 44 yrs (2) 45 74 yrs (2) 1975 1980 1985 1990 1995 Cervix uteri: Adenocarcinoma Annual crude incidence rate (per 100,000) No data available All ages (2) 15 44 yrs (2) 45 74 yrs (2) 1975 1980 1985 1990 1995 Data accessed on 27 Apr 2015. a Estimated annual percentage change based on the trend variable from the net drift for the most recent two 5-year periods. 1 Vaccarella S, Lortet-Tieulent J, Plummer M, Franceschi S, Bray F. Worldwide trends in cervical cancer incidence: Impact of screening against changes in disease risk factors. eur J Cancer 2013;49:3262-73. 2 Ferlay J, Bray F, Steliarova-Foucher E and Forman D. Cancer Incidence in Five Continents, CI5plus: IARC CancerBase No. 9 [Internet]. Lyon, France: International Agency for Research on Cancer; 2014. Available from: http://ci5.iarc.fr

3 BURDEN OF HPV RELATED CANCERS - 12-3.1.3 Cervical cancer incidence in Viet Nam across South-Eastern Asia Figure 8: Age-standardised incidence rates of cervical cancer of Viet Nam (estimates for 2012) Cambodia 23.8 Myanmar 20.6 Thailand Indonesia Brunei 16.9 17.8 17.3 Philippines Malaysia 16 15.6 Timor Leste Laos 12.5 13.3 Viet Nam 10.6 Singapore 8.1 0 5 10 15 20 25 30 Cervical cancer: Age standardised mortality rate per 100,000 women World Standard. Female (All ages) Data accessed on 15 Nov 2015. Rates per 100,000 women per year. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr. Figure 9: Comparison of age-specific cervical cancer incidence rates in Viet Nam, within the region, and the rest of world Age specific rates of cervical cancer 50 40 30 20 10 Viet Nam South Eastern Asia World 0 15 19 20 24 25 29 30 34 35 39 40 44 45 49 50 54 55 59 60 64 65 69 70 74 >=75 Age group (years) Data accessed on 15 Nov 2015. Rates per 100,000 women per year. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr.

3 BURDEN OF HPV RELATED CANCERS - 13 - Figure 10: Annual number of new cases of cervical cancer by age group in Viet Nam (estimates for 2012) Viet Nam South Eastern Asia Annual number of new cases of cervical cancer 9000 7500 6000 4500 3000 1500 0 7774 7576 6616 6309 4524 4617 3341 2742 2797 2443 1210 657 788 799 671 * 228 349 495 422 248 * 164 189 15 19 20 24 25 29 30 34 35 39 40 44 45 49 50 54 55 59 60 64 65 69 70 74 >=75 Age group (years) *29 cases for Viet Nam and 122 cases for South-Eastern Asia in the 15-19 age group. 106 cases for Viet Nam and 484 cases for South-Eastern Asia in the 20-24 age group. Data accessed on 15 Nov 2015. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr.

3 BURDEN OF HPV RELATED CANCERS - 14-3.1.4 Cervical cancer mortality in Viet Nam KEY STATS. About 2,423 cervical cancer deaths occur annually in Viet Nam (estimations for 2012). Cervical cancer ranks* as the 6 th leading cause of female cancer deaths in Viet Nam. Cervical cancer is the 6 th leading cause of cancer deaths in women aged 15 to 44 years in Viet Nam. * Ranking of cervical cancer incidence to other cancers among all women according to highest incidence rates (ranking 1st). Ranking is based on crude incidence rates (actual number of cervical cancer cases). Ranking using age-standardized rate (ASR) may differ. Table 6: Cervical cancer mortality in Viet Nam (estimates for 2012) Indicator Viet Nam South-Eastern Asia World Annual number of deaths 2,423 23,989 265,672 Crude mortality rate a 5.3 7.9 7.6 Age-standardized mortality rate a 5.2 7.9 6.8 Cumulative risk (%) at 75 years old b 0.6 0.9 0.8 Data accessed on 15 Nov 2015. Mortality data is available from incomplete or sample vital registration sources. Mortality rates were estimated as the weighted average of regional rates. For more detailed methods of estimation please refer to http://globocan.iarc.fr/old/method/method.asp?country=704 a Rates per 100,000 women per year. b Cumulative risk (mortality) is the probability or risk of individuals dying from the disease during ages 0-74 years. For cancer, it is expressed as the % of new born children who would be expected to die from a particular cancer before the age of 75 if they had the rates of cancer observed in the period in the absence of competing causes. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr.

3 BURDEN OF HPV RELATED CANCERS - 15 - Figure 11: Comparison of cervical cancer mortality to other cancers in women of all ages in Viet Nam (estimates for 2012) Lung Liver Breast Stomach Colorectum (a) Cervix uteri Leukaemia Nasopharynx Ovary Corpus uteri Brain, nervous system Thyroid Non Hodgkin lymphoma (b) Lip, oral cavity Pancreas Oesophagus Kidney Multiple myeloma Other pharynx Gallbladder Bladder Hodgkin lymphoma Larynx Melanoma of skin Kaposi sarcoma (c) 2.1 2.0 1.9 1.8 0.7 1.7 1.7 0.7 0.7 0.6 0.5 0.4 0.4 0.3 0.2 0.2 0.1 0.1 6.3 5.3 3.5 11.4 9.6 10.3 10.9 0 5 10 15 20 25 30 Annual crude mortality rate per 100,000 Viet Nam: Female (All ages) Data accessed on 15 Nov 2015. a Includes anal cancer (C21). b Includes HIV disease resulting in malignant neoplasms (B21). c Includes B21.0 (HIV disease resulting in Kaposi sarcoma). Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr.

3 BURDEN OF HPV RELATED CANCERS - 16 - Figure 12: Comparison of age-specific mortality rates of cervical cancer to other cancers among women 15-44 years of age in Viet Nam (estimates for 2012) Breast Leukaemia Liver Stomach Lung Cervix uteri Colorectum (a) Brain, nervous system Ovary Nasopharynx Non Hodgkin lymphoma (b) Corpus uteri Thyroid Kidney Oesophagus Lip, oral cavity Pancreas Other pharynx Multiple myeloma Hodgkin lymphoma Gallbladder Bladder Larynx Melanoma of skin Kaposi sarcoma (c) 0.2 0.30.50.7 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.7 0.81.11.3 1.9 2.4 2.5 2.6 5.0 1.9 0 5 10 Annual crude mortality rate per 100,000 Viet Nam: Female (15 44 years) Data accessed on 15 Nov 2015. a Includes anal cancer (C21). b Includes HIV disease resulting in malignant neoplasms (B21). c Includes B21.0 (HIV disease resulting in Kaposi sarcoma). Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr.

3 BURDEN OF HPV RELATED CANCERS - 17 - Figure 13: Annual number of deaths and age-specific mortality rates of cervical cancer in Viet Nam (estimates for 2012) 25 20 15 10 5 0 15 19 20 24 Age specific rates of cervical cancer 25 29 30 34 35 39 40 44 45 49 50 54 55 59 60 64 65 69 70 74 Annual number of deaths of cervical cancer 75+ 2000 1750 1500 1250 1000 750 500 250 0 223* 1600 60 64 yrs: 300 cases 55 59 yrs: 393 cases 50 54 yrs: 385 cases 45 49 yrs: 315 cases 40 44 yrs: 207 cases 599 15 39 40 64 65+ Age group (years) * 15-19 yrs: 3 cases. 20-24 yrs: 12 cases. 25-29 yrs: 31 cases. 30-34 yrs: 58 cases. 35-39 yrs: 119 cases. Data accessed on 15 Nov 2015. Rates per 100,000 women per year. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr.

3 BURDEN OF HPV RELATED CANCERS - 18-3.1.5 Cervical cancer mortality in Viet Nam across South-Eastern Asia Figure 14: Comparison of age-standardised cervical cancer mortality rates in Viet Nam and countries within the region (estimates for 2012) Cambodia 13.4 Myanmar 12.3 Thailand 9.7 Timor Leste Indonesia 8.1 8.1 Philippines Laos 7.5 7.4 Brunei 6 Viet Nam Malaysia 4.7 5.2 Singapore 2.6 0 5 10 15 20 Cervical cancer: Age standardised mortality rate per 100,000 women World Standard. Female (All ages) Data accessed on 15 Nov 2015. Rates per 100,000 women per year. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr. Figure 15: Comparison of age-specific cervical cancer mortality rates in Viet Nam, within its region and the rest of the world Age specific rates of cervical cancer 40 30 20 10 Viet Nam South Eastern Asia World 0 15 19 20 24 25 29 30 34 35 39 40 44 45 49 50 54 55 59 60 64 65 69 70 74 >=75 Age group (years) Data accessed on 15 Nov 2015. Rates per 100,000 women per year. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr.

3 BURDEN OF HPV RELATED CANCERS - 19 - Figure 16: Annual deaths number of cervical cancer by age group in Viet Nam (estimates for 2012) Viet Nam South Eastern Asia 3500 3369 3300 Annual number of new cases of cervical cancer 3000 2500 2000 1500 1000 500 0 2933 2820 2839 2393 2099 2062 1227 594 385 393 315 300 243 207 * 119 * 31 58 206 160 233 15 19 20 24 25 29 30 34 35 39 40 44 45 49 50 54 55 59 60 64 65 69 70 74 >=75 Age group (years) *3 cases for Viet Nam and 20 cases for South-Eastern Asia in the 15-19 age group. 12 cases for Viet Nam and 89 cases for South-Eastern Asia in the 20-24 age group. Data accessed on 15 Nov 2015. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr.

3 BURDEN OF HPV RELATED CANCERS - 20-3.1.6 Cervical cancer incidence and mortality comparison, Premature deaths and disability in Viet Nam Figure 17: Comparison of age-specific cervical cancer incidence and mortality rates in Viet Nam (estimates for 2012) Age specific rates of cervical cancer 30 20 10 Incidence (N) Mortality (N) 0 15 19 20 24 25 29 30 34 35 39 40 44 45 49 50 54 55 59 60 64 65 69 70 74 >=75 Age group (years) Data accessed on 15 Nov 2015. Rates per 100,000 women per year. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr. Table 7: Premature deaths and disability from cervical cancer in Viet Nam, South-Eastern Asia and the rest of the world (estimates for 2008) Viet Nam South-Eastern Asia World Indicator Number ASR (W) Number ASR (W) Number ASR (W) Estimated disability-adjusted life 77,107 175 692,606 243 8,738,004 293 years (DALYs) Years of life lost (YLLs) 67,354 155 615,604 218 7,788,282 264 Years lived with disability (YLDs) 9,752 20 77,002 25 949,722 28 Data accessed on 04 Nov 2013. Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, Bray F. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012 Nov 24;380(9856):1840-50.

3 BURDEN OF HPV RELATED CANCERS - 21 - Figure 18: Comparison of annual premature deaths and disability from cervical cancer in Viet Nam to other cancers among women (estimates for 2008) Liver ca. Lung ca. Stomach ca. Leukaemia Breast ca. Cervix uteri ca. Colorectal ca. Ca. of the brain and CNS Corpus uteri ca. Nasopharyngeal ca. Ovarian ca. Non Hodgkin lymphoma Kidney ca. Oesophageal ca. Ca. of the lip and oral cavity Pancreatic ca. Melanoma of skin Thyroid ca. Other pharynx ca. Laryngeal ca. Bladder ca. Hodgkin lymphoma Multiple myeloma Gallbladder Kaposi sarcoma 55,326 49,003 44,766 26,447 13,679 13,678 9,576 7,967 7,521 6,496 4,114 4,019 3,640 3,183 2,710 2,601 2,352 1,688 0 77,107 89,471 89,121 116,223 135,105 190,588 YLLs YLDs 0 42000 84000 126000 168000 210000 Estimated disability adjusted life years (DALYs). Data accessed on 04 Nov 2013. CNS: Central Nervous System; YLDs: years lived with disability; YLLs: Years of life lost; Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, Bray F. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012 Nov 24;380(9856):1840-50.

3 BURDEN OF HPV RELATED CANCERS - 22-3.2 Anogenital cancers other than the cervix Data on HPV role in anogenital cancers other than cervix are limited, but there is an increasing body of evidence strongly linking HPV DNA with cancers of anus, vulva, vagina, and penis. Although these cancers are much less frequent compared to cervical cancer, their association with HPV make them potentially preventable and subject to similar preventative strategies as those for cervical cancer. (Vaccine 2006, Vol. 24, Suppl 3; Vaccine 2008, Vol. 26, Suppl 10; Vaccine 2012, Vol. 30, Suppl 5; IARC Monographs 2007, Vol. 90). 3.2.1 Anal cancer Anal cancer is rare in the general population with an average worldwide incidence of 1 per 100,000, but is reported to be increasing in more developed regions. Globally, there are an estimated 27,000 new cases every year (de Martel C et al. Lancet Oncol 2012;13(6):607-15). Women have higher incidences of anal cancer than men. Incidence is particularly high among populations of men who have sex with men (MSM), women with history of cervical or vulvar cancer, and immunosuppressed populations, including those who are HIV-infected and patients with a history of organ transplantation. These cancers are predominantly squamous cell carcinoma, adenocarcinomas, or basaloid and cloacogenic carcinomas. Table 8: Anal cancer incidence in Viet Nam by cancer registry and sex MALE FEMALE Cancer registry 1 Period N cases a Crude rate b ASR b N cases a Crude rate c ASR c Hanoi 1993-1997 7 0.1 0.2 5 0.1 0.1 Ho Chi Minh City 1995-1998 32 0.4 0.6 36 0.4 0.4 Data accessed on 05 May 2015. ASR: Age-standardized rate, Standardized rates have been estimated using the direct method and the World population as the reference; Please refer to original source (available at http://ci5.iarc.fr/ci5i-ix/ci5i-ix.htm) a Accumulated number of cases during the period in the population covered by the corresponding registry. b Rates per 100,000 men per year. c Rates per 100,000 women per year. 1 Parkin, D.M., Whelan, S.L., Ferlay, J., Teppo, L., and Thomas, D.B., eds (2002). Cancer Incidence in Five Continents, Vol. VIII. IARC Scientific Publications No. 155, Lyon, IARC. Figure 19: Anal cancer incidence rates by age group in Viet Nam (cancer registry data) REGISTRIES Hanoi Ho Chi Minh City 6 Age specific rates of anal cancer 4 2 0 * * 15 19 20 29 30 39 40 49 50 59 60 69 70+ Age group (years) *No cases were registered for this age group. Female (Continued on next page) Male

3 BURDEN OF HPV RELATED CANCERS - 23 - ( Figure 19 continued from previous page) Data accessed on 05 May 2015. Pooled estimate of the following registries: Hanoi, Ho Chi Minh City Rates per 100,000 per year. Parkin, D.M., Whelan, S.L., Ferlay, J., Teppo, L., and Thomas, D.B., eds (2002). Cancer Incidence in Five Continents, Vol. VIII. IARC Scientific Publications No. 155, Lyon, IARC. Figure 20: Time trends in anal cancer incidence in Viet Nam (cancer registry data) Anal cancer in men Annual crude incidence rate (per 100,000) No data available All ages 15 44 yrs 45 74 yrs 1975 1980 1985 1990 1995 Anal cancer in women Annual crude incidence rate (per 100,000) No data available All ages 15 44 yrs 45 74 yrs 1975 1980 1985 1990 1995 Year Data accessed on 27 Apr 2015. Ferlay J, Bray F, Steliarova-Foucher E and Forman D. Cancer Incidence in Five Continents, CI5plus: IARC CancerBase No. 9 [Internet]. Lyon, France: International Agency for Research on Cancer; 2014. Available from: http://ci5.iarc.fr